News
![GECI INTERNATIONAL : 2021-22 FULL-YEAR REVENUES](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
GECI INTERNATIONAL : 2021-22 FULL-YEAR REVENUES
GECI INTERNATIONAL CONFIRMS ITS RETURN TO GROWTH, WITH 2021-22 FULL-YEAR REVENUES UP 7.6%
GECI International, the Digital and Technology specialist, returned to growth in FY 2021-22, securing
![PRISMAFLEX INTERNATIONAL : Strong growth in Q4: +39.5% - Solid annual turnover: EUR 48.9 million (+29%)](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
PRISMAFLEX INTERNATIONAL : Strong growth in Q4: +39.5% - Solid annual turnover: EUR 48.9 million (+29%)
Significant points:
- Printing activity attained its highest annual level on record, driven by sustained demand. Inflationary pressures however impact margins.
- Hardware activity posts moderate
![DOLFINES (EX DIETSWELL) : Erratum on Q1 2022 revenue](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
DOLFINES (EX DIETSWELL) : Erratum on Q1 2022 revenue
Montigny Le Bretonneux, May 2, 2022
Erratum on Q1 2022 revenue
In the press release published Friday, April 29 on the 2021 results, an error slipped into the paragraph on the activity of the 1st
![DOLFINES (EX DIETSWELL) : 2021 Resilts](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
DOLFINES (EX DIETSWELL) : 2021 Resilts
Montigny Le Bretonneux, April 29, 2022
2021 RESULTS
- A 2021 financial year characterized by preparing for future growth
- Significant increase in activity in the 1st quarter of 2022, which benefits
![TRANSITION EVERGREEN : 2021 annual results: strong increase in the value of Transition Evergreen assets, demonstrating the appeal of holdings and their growth performance](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
TRANSITION EVERGREEN : 2021 annual results: strong increase in the value of Transition Evergreen assets, demonstrating the appeal of holdings and their growth performance
2021 annual results: strong increase in the value of Transition Evergreen assets, demonstrating the appeal of holdings and their growth performance
FY 2021 net income: €30.9m
Restated NAV[1] of
![GROUPE LDLC : 2021/2022 REVENUES OF EUR 684.9M](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
GROUPE LDLC : 2021/2022 REVENUES OF EUR 684.9M
LIMONEST, 28 APRIL 2022, 5.45 PM
- Q4 REVENUES OF €160.1M, FOLLOWING A RETURN TO A NORMAL RATE OF CONSUMPTION
- FULL-YEAR BTOB REVENUES UP 4.8% TO €194.7M
- OBJECTIVE OF STRENGTHENING LDLC'S BRAND
![Availability of Netgem's annual financial report as of December 31, 2021](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Availability of Netgem's annual financial report as of December 31, 2021
Paris, April 28, 2022,
Netgem announces that it has made available to the public and filed with the Autorité des Marchés Financiers its annual financial report as of December 31, 2021.
The annual
![DOLFINES (EX DIETSWELL) : DOLFINES raises 200,000 euros](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
DOLFINES (EX DIETSWELL) : DOLFINES raises 200,000 euros
Montigny Le Bretonneux, April 27, 2022
DOLFINES RAISES €200,000 IN THE FORM OF BONDS CONVERTIBLE INTO SHARES WITH SHARE PURCHASE WARRANTS
DOLFINES (the "Company") recalls having signed, on June 15
![Theranexus publishes its 2021 full-year results And announces a shift of its strategic focus to rare neurological diseases](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Theranexus publishes its 2021 full-year results And announces a shift of its strategic focus to rare neurological diseases
Lyon, France – 25 April 2022 – 7:00 am CEST –Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating
![BD MULTIMEDIA : Lauch of the ICO of the "PLAY TO EARN" game OLYMPUS](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
BD MULTIMEDIA : Lauch of the ICO of the "PLAY TO EARN" game OLYMPUS
The Group announces its first "Play to Earn" type game whose economy is centered on the new $OLYMP token and NFTs that can be used in the game.
With the acquisition of a 37.5% stake in OLYMPUS GAME
![AGROGENERATION : Information on the situation in Ukraine](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
AGROGENERATION : Information on the situation in Ukraine
Paris, April,19th, 2022
AgroGeneration, a Ukraine based grain and oilseed producer, provides an update on the current company's performance and gives an overview of the impacts of the Russian
![NETGEM : 2021 Results and 2022 Objectives](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
NETGEM : 2021 Results and 2022 Objectives
2021 Results
Growth of more than 30% in the number of subscribers to 363.000 at year-end
Operational performance up sharply: EBITDA of €4.3m (x 4.8)
Increase in net cash to €4.0 million (+€2.2
![DOLFINES (EX DIETSWELL) : Progress report at the end of March 2022](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
DOLFINES (EX DIETSWELL) : Progress report at the end of March 2022
Press release – March 30, 2022
Progress report at the end of March 2022
DOLFINES, an independent specialist in engineering and services in the renewable and conventional energy industry, offers a
![Prismaflex International inform the company is eligible for PEA-PME](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Prismaflex International inform the company is eligible for PEA-PME
PRISMAFLEX INTERNATIONAL, listed on the Euronext GrowthTH Paris (Code ISIN FR0004044600), confirms its eligibility for the small and mid-caps PEA-PME equity savings vehicle, in accordance with the
![STREAMWIDE : Confirmed earnings and investment growth in 2021](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
STREAMWIDE : Confirmed earnings and investment growth in 2021
_ EBITDA: €9.4m (up 23%)
EBIT: €4.9m (up 22%)
NET INCOME: €4.1m (up 25%)
_ STREAMWIDE (FR0010528059 – ALSTW – eligible for the French
![AGROGENERATION : Year-end results disclosure potential postponement](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
AGROGENERATION : Year-end results disclosure potential postponement
Paris, March 3rd, 2022
AgroGeneration, a Ukraine based grain and oilseed producer, considering the political situation in Ukraine and its impact on the work of its teams, suffered of difficulties
![GROUPE CIOA : CIOA announces a 165 million EUR financing to accelerate its development](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
GROUPE CIOA : CIOA announces a 165 million EUR financing to accelerate its development
PRESS RELEASE La Garde (France), March 1st 2022
CIOA announces a 165 million euro financing to accelerate its development
CIOA Group, an engineering and development company, announces a €165m
![AGROGENERATION : Information on the situation in Ukraine](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
AGROGENERATION : Information on the situation in Ukraine
Paris, February 28th, 2022
AgroGeneration, a Ukraine based grain and oilseed producer, suspended all activities (spring sowing campaign preparation) of the Group starting from February 24th, the
![THERANEXUS UNVEILS ITS SCIENTIFIC ADVANCES ON THE OCCASION OF WORLD RARE DISEASE DAY 2022](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
THERANEXUS UNVEILS ITS SCIENTIFIC ADVANCES ON THE OCCASION OF WORLD RARE DISEASE DAY 2022
- · New milestone for NeuroLead, the active agent screening platform
- · New publications in scientific journals
- · Start of Phase I/II clinical trial for Batten disease
Lyon, 28 February 2022
![GROUPE LDLC : TRADING UPDATE IN RELATION TO A HIGHLY DISRUPTED MARKET CONTEXT](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
GROUPE LDLC : TRADING UPDATE IN RELATION TO A HIGHLY DISRUPTED MARKET CONTEXT
LIMONEST, 24 FEBRUARY 2022, 6.00 PM
- SHARP DECLINE IN BUSINESS IN FEBRUARY
- ADJUSTMENT OF ANNUAL TARGETS FOR 2021-2022: REVENUE OF AROUND €680M AND EBITDA OF AROUND €55M
- SOLID BUSINESS
![STREAMWIDE : 2021 Revenue: EUR 16.7m (up 20%) Another year of strong growth driven by the platforms business (up 32%)](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
STREAMWIDE : 2021 Revenue: EUR 16.7m (up 20%) Another year of strong growth driven by the platforms business (up 32%)
_ STREAMWIDE (FR0010528059 – ALSTW – eligible for the French PEA-PME), the
![STREAMWIDE : GROUP MANAGEMENT TEAM STRENGTHENED - RONAN JAMET APPOINTED VP ENGINEERING - ELODIE LOPES APPOINTED GROUP HRD](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
STREAMWIDE : GROUP MANAGEMENT TEAM STRENGTHENED - RONAN JAMET APPOINTED VP ENGINEERING - ELODIE LOPES APPOINTED GROUP HRD
_ STREAMWIDE (FR0010528059 - ALSTW - eligible for French PEA-PME), the expert in
![THERANEXUS AND BBDF START RECRUITMENT FOR PHASE I/II TRIAL IN BATTEN DISEASE PATIENTS](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
THERANEXUS AND BBDF START RECRUITMENT FOR PHASE I/II TRIAL IN BATTEN DISEASE PATIENTS
Lyon, France – Austin, TX, USA - 3 February 2022 – Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates
![GROUPE LDLC : 2021/2022 NINE-MONTH REVENUES](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
GROUPE LDLC : 2021/2022 NINE-MONTH REVENUES
LIMONEST, 27 JANUARY 2022, 5.45 PM
- 9-MONTH REVENUES DIP -3.2% TO €524.8M
- STRONG MOMENTUM IN BTOB AND STORE SALES
- Q3 REVENUES OF €191.4M IMPACTED BY SHORTAGE OF GRAPHICS CARDS
Olivier de la
![DOLFINES (EX DIETSWELL) : DOLFINES continues to strenghten its teams](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
DOLFINES (EX DIETSWELL) : DOLFINES continues to strenghten its teams
Press release – January 26, 2022
DOLFINES CONTINUES TO STRENGTHEN ITS TEAMS TO SUPPORT ITS DEVELOPMENT
DOLFINES announces several appointments to strengthen its development capacities on its two